LONDON, GB / ACCESSWIRE / January 9, 2025 / Nanomerics Ltd., a private speciality pharmaceutical company today announced that it…
Mark Orsmond, a highly respected business professional in Canadian Healthcare, Appointed Executive ChairMichael Nemirow Joins as Director, Bringing Decades of…
Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciencesMeet BioLizard’s…
Accelerating IMPT-314 in large B-cell lymphoma; remain on track to initiate pivotal trial in the 3rd line+ setting in 2025…
Appointment adds business, market and partner development expertise to FYR board Addition highlights FYR’s evolution into partner of choice for…
Two additional TEASE-3 participants who recently completed 24 months of therapy showed no disease progression, consistent with prior results. A…
VANCOUVER, British Columbia and LAS VEGAS, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV:…
Divestment of Amwell Psychiatric Care intended to focus product portfolio on key growth initiatives Company reiterates guidance for 2024 BOSTON,…
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company…
The panel will discuss the value proposition for investing in women’s health. J.P. Morgan is hosting a three-panel women’s health…